The invention relates to the technical field of
nasal disease treatment, in particular to a
plant composition for treating nasal polyp and nasal gland hypertrophy, which is prepared from the following
raw material medicines in parts by
mass: 10 to 15 parts of
flos magnoliae, 8 to 12 parts of radix angelicae, 10 to 20 parts of radix scutellariae, 15 to 25 parts of
honeysuckle flower, 10 to 18 parts of fructus forsythiae, 5 to 10 parts of radix platycodonis, 3 to 8 parts of herba menthae, 10 to 20 parts of herba houttuyniae and 5 to 12 parts of herba centipedae. And the following active extraction components in parts by weight: 1-3 parts of bromelain, 0.5-2 parts of
quercetin, 0.5-1.5 parts of
curcumin and 1-4 parts of a
frankincense serrata serrata extract.
Nasal cavity inflammation and
tissue edema are effectively relieved through a combined effect, firstly,
flos magnoliae and radix angelicae in the formula can dissipate wind-cold, dredge nasal orifices and directly improve the ventilation function of the
nasal cavity, meanwhile, radix scutellariae,
honeysuckle and other medicinal materials clear away damp-heat
toxin in the body through the effects of clearing away heat and
drying dampness,
inflammatory response is inhibited from the source, and the effect is remarkable. By matching with modern active ingredients such as bromelain and
curcumin, the release of inflammatory mediators can be further blocked, and the capillary permeability is reduced.